Canopy Growth Expands Spectrum Therapeutics Portfolio in Australia with New Softgels

Expanded formats strengthen Canopy Growth’s medical offering as patient demand rises SMITHS FALLS, ON, November 18, 2025 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has expanded its Spectrum Therapeutics portfolio in Australia with the availability … Continue reading Canopy Growth Expands Spectrum Therapeutics Portfolio in Australia with New Softgels